Abstract. Salvianolic acid B (SalB) a water-soluble phenolic compound, extracted from Salvia miltiorrhiza, has previously been demonstrated to reverse tumor multidrug resistance (MDR), including in colorectal cancer. Reactive oxygen species (ROS) are oxygen radicals generated during aerobic metabolism (superoxide and hydroxyl radicals) and superoxide easily generating free radicals (H 2 O 2 ). The concept that increased ROS levels can lead to augmented tumor cell-sensitivity to chemotherapy drugs has become notable. The aim of the present study was to elucidate the role of ROS in mediating the effect of SalB on drug resistance and the correlation with drug resistance-associated protein, P-glycoprotein (P-gp), and apoptosis-associated proteins, B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X (Bax). In the current study, through utilizing the multidrug resistant colorectal cancer cell line, HCT-8/VCR, it was demonstrate that SalB reversed MDR in HCT-8/VCR. In addition, SalB significantly increased ROS levels, which may have accelerated the apoptosis of HCT-8/VCR cells by downregulating Bcl-2 and increasing Bax protein expression. Furthermore the increased intracellular ROS levels may have inhibited P-gp expression at the gene and protein levels. In conclusion, the data of the current study demonstrate that SalB reversed MDR in HCT-8/VCR cells, and the effect is associated with increased ROS levels, which may downregulate P-gp expression and promote tumor cell apoptosis, which in turn increases the sensitivity of drug-resistant cells to chemotherapy drugs.
Introduction
Colorectal cancer is a gastrointestinal malignancy, and the third most common cause of cancer and cancer-associated mortality (1) . The 5-year survival rate of colorectal cancer patients is 50-55% (2) . Chemotherapy is a primary therapeutic strategy for colorectal cancer; however, multidrug resistance (MDR) is a key reason for the failure of this treatment. Identification of effective MDR reversal strategies is therefore required to address this issue.
Reactive oxygen species (ROS), which are primarily produced by mitochondria, have strong reactivity and a short life cycle, and may damage the majority of organelles, including mitochondria. Previously, ROS were considered to be toxic substances that cause cell damage and play an important role in the occurrence and development of tumors. However, in recent years, anti-tumor effects exerted by ROS have been demonstrated. Multiple studies have demonstrated that long-term administration of a drug may reduce intracellular ROS levels and convert sensitive tumor cells into drug-resistant cells (3) . ROS concentrations moderately greater than physiological levels downregulate P-glycoprotein (P-gp) expression and increase tumor cell sensitivity to chemotherapy drugs (4) . In addition, ROS induce apoptosis of tumor cells via various pathways, increasing their chemotherapeutic sensitivity (5, 6) .
The B-cell lymphoma 2 (Bcl-2) family is critical in the mitochondrial apoptotic pathway; Bcl-2 (anti-apoptotic) and Bcl-2-associated X (Bax; pro-apoptotic) are important members of this family. The mitochondria-dependent apoptosis pathway is a primary pathway of apoptosis, and mitochondrial membrane potential decline is a feature of early apoptosis (7) . Bax translocates from the cytoplasm to mitochondria and associates with the mitochondrial membrane, to promote the opening of the mitochondrial permeability transition pore, which leads to the loss of mitochondrial membrane potential and the destruction of membrane integrity, thereby promoting the release of mitochondrial pro-apoptotic factors and inducing cell apoptosis. The pro-apoptotic effect of Bax may be inhibited by overexpression of Bcl-2. P-gp, an important member of the ABC transporter superfamily, is encoded by the MDR1 gene and functions as an energy-dependent drug efflux pump. P-gp-mediated drug efflux is the classical mechanism underlying MDR. In colorectal cancer, P-gp expression levels and frequencies are high, with up to 96% of cells expressing this molecule (8) . A previous study has revealed that P-gp function in MDR colorectal cancer cells is significantly enhanced, and that P-gp serves an important role in the generation and maintenance of colorectal cancer drug resistance (9) .
Salvianolic acid B (SalB) is a water-soluble phenolic compound, extracted from Salvia miltiorrhiza. Its role in reversing tumor MDR has attracted increasing attention (10, 11) . In the present study, SalB was used to treat the MDR colorectal cancer cell line HCT-8/VCR, and explore its effect on drug resistance. The present study aimed to determine the potential mechanism by which SalB reverses MDR in colorectal cancer by assessing its effects on ROS levels, P-gp expression and the levels of apoptosis-associated factors in HCT-8/VCR. Cell culture. HCT-8 and HCT-8/VCR cells were cultured in RPMI-1640 medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.), 100 µg/ml penicillin and 100 µg/ml streptomycin. VCR (800 ng/ml) was added in the culture medium for HCT-8/VCR cells to maintain drug resistance. Cells were incubated at 37˚C in a humid environment containing 5% CO 2 . The VCR in the medium was removed 1 week before experiments were performed, and cells in the logarithmic phase were used. . HCT-8 and HCT-8/VCR cells in the logarithmic phase were seeded at 5x10 3 /ml/well (100 µl) in 96-well plates. Chemotherapy drugs, VCR, 5-FU, CDDP and Taxol, at five different concentrations (0.01, 0.1, 1, 10 and 100 µg/ml), were added following overnight incubation. Three replicates were performed for each condition, and 10 µl CCK-8 was added after 48 h incubation. After 40 min, absorbance was read by using a microplate reader at 450 nm, with a reference wavelength of 650 nm. The following equation was used to calculate growth inhibition: Cell suppression rate (%) = (1-OD in the study group/OD in the control group) x 100. The experiment was repeated 3 times. SPSS 18.0 (SPSS, Inc., Chicago, IL, USA) was employed to calculate the median inhibitory concentration (IC 50 ) of each drug. The cell resistance index was calculated as follows: resistance index (%) = IC 50 resistant cells/IC 50 parent cells x100.
Materials and methods

Drugs
Assessment of drug resistance in HCT-8/VCR cells by
Assessment of the cytotoxic effect of SalB on HCT-8/VCR cells by CCK-8.
Inhibition rates were calculated as described above. Then, drug concentration and cell inhibition rate were used as ordinates to plot a dose-response curve of SalB for HCT-8/VCR. IC 50 and non-toxic dose (IC 20 ) were derived from the curve. The experiment was repeated three times.
Evaluation of reverse index for drug resistance of SalB in HCT-8/VCR by CCK-8.
IC 50 values for VCR, 5-FU, CDDP and Taxol for HCT-8/VCR cells were calculated as described above. In addition, the IC 50 values of their combination with SalB for HCT-8/VCR cells were also calculated. Reverse index for drug resistance was calculated as follows, with the experiment repeated 3 times. Reverse index=IC 50 before combination/IC 50 after combination. Dichlorofluorescin diacetate (DCFH-DA; 1 ml) diluted with serum free RPMI-1640 culture medium was added to cells, which were cultured at 37˚C for 30 min and washed with PBS three times to remove free DCFH-DA. Then, cells were harvested and resuspended in PBS for FCM analysis using a FACSCalibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). Untreated cells were used as controls; 10,000 cells were detected in each sample, using average fluorescence intensity to reflect intracellular ROS levels. Data were analyzed using FlowJo software version 10.0.7 (FlowJo, LLC, Ashland, OR). The experiment was repeated three times.
Detection of ROS levels by flow cytometry (FCM)
Effect of SalB on HCT-8/VCR apoptosis rate. FCM was perfor med with cells divided into 6 groups: HCT-8/VCR, HCT-8/VCR + SalB20, HCT-8/VCR + SalB40, HCT-8/VCR + SalB80, HCT-8/VCR + SalB80 + NAC, and HCT-8/VCR + H 2 O 2 groups. They were treated as described above for 48 h at 37˚C with 5% CO 2 . After washing, cells were resuspended in PBS to 1x10 6 cells/ml. To 100 µl cell suspensions, 5 µl Annexin V-fluorescein isothiocyanate and 5 µl propidium iodide were added. The mixture was gently shaken and incubated at room temperature, and shielded from direct sunlight for 15 min. FCM was performed immediately after washing. The experiment was repeated three times. For reverse transcription-quantitative polymerase chain reaction (RT-qPCR), cells were seeded at 5x10 5 /ml. Total RNA was extracted using the RNeasy Extraction kit (catalog no. 9108Q; Takara Biotechnology Co., Ltd., Dalian, China), and 1 µg total RNA was reverse-transcribed to cDNA using a FastQuant RT kit (catalog no. KR106; Tiangen Biotech Co., Ltd., Beijing, China). Thermocycling conditions for RT were as follows: An initial step at 42˚C for 15 min followed by 95˚C for 3 min. qPCR on the obtained cDNA was performed in triplicate using the SYBR ® -Green PCR Master mix (catalog no. FP302; Tiangen Biotech Co., Ltd.), with thermocycling conditions as follows: An initial denaturation step at 95˚C for 2 min, followed by 40 cycles of 95˚C for 10 sec and 60˚C for 30 sec. The quantitation cycle (Cq) values of each sample were calculated and normalized to GAPDH, which served as an internal control, using the 2 -ΔΔCq method (12) . The primers used are listed in Table I .
Effect of SalB on MDR1 mRNA expression in HCT-
Influence of SalB on P-gp, Bcl-2 and Bax protein expression in HCT-8/VCR.
The protein expression levels were detected by western blotting. Grouping and treatments were the same as apoptosis analysis. Cytoplasmic and nuclear proteins were extracted using radioimmunoprecipitation assay lysis buffer (catalog no. P0013B; Beyotime Institute of Biotechnology), according to the manufacturer's protocol and protein content was determined using a Bicinchoninic Acid Protein assay kit (catalog no. P0010; Beyotime Institute of Biotechnology). Total protein (30 µg) was resolved by SDS-PAGE. Blocking was performed using 5% bovine serum albumin (BSA) for 2 h at room temperature following membrane transfer. Anti-P-gp, anti-Bcl-2, anti-Bax and anti-GAPDH antibodies [all diluted 1:1,000 with 5% BSA in TBS containing 0.1% Tween-20 (TBST)] were added and incubated overnight at 4˚C. Following three washes with TBST, membranes were probed with a horseradish peroxidase-conjugated secondary antibody (1:1,000) for 2 h at 37˚C. Membranes were washed three times with TBST, and protein bands were visualized using an Enhanced Chemiluminiscence reagent (catalog no. P0018; Beyotime Institute of Biotechnology). Quantity-One software version 4.6.2 (Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used for densitometry. Experiments were repeated three times.
Statistical analysis. Data were analyzed using SPSS 18.0 (SPSS, Inc., Chicago, IL, USA), and presented as the mean ± standard deviation. One-way analysis of variance was used for comparisons among groups with Student-Newman-Keuls-q test used for multiple comparisons between groups. P<0.05 was considered to indicate a statistically significant difference. (Table II) demonstrated that HCT-8/VCR were resistant to the four chemotherapy drugs (VCR, 5-FU, CDDP and Taxol), with significant differences in the IC 50 values of cytotoxicity compared with the sensitive HCT-8 cells (P<0.01).
Results
Multidrug resistance in HCT-8/VCR cells. CCK-8 assay data
Cytotoxicity of SalB in HCT-8/VCR. Cytotoxicity of SalB in
HCT-8/VCR was assessed by the CCK-8 method. As demonstrated in Table III , SalB significantly inhibited HCT-8/VCR proliferation in a concentration-dependent manner in a certain concentration range. IC 20 and IC 50 were 20.79±4.76 µg/ml and 114.79±10.94 µg/ml, respectively. Concentrations ≤IC 20 were selected as non-cytotoxic dose to perform drug resistance experiments.
Reverse index of SalB for drug resistance in HCT-8/VCR.
As demonstrated in Table IV , CCK-8 data demonstrated that (Fig. 2) . Fig. 3 , SalB induced HCT-8/VCR apoptosis in a concentration-dependent manner. In addition, apoptosis rates in cells treated with SalB at 40 and 80 µg/ml (no significant difference between both groups) were significantly higher compared with the untreated control group (P<0.01). HCT-8/VCR apoptosis rates in cells receiving SalB after pretreatment with NAC (5 mM) for 2 h were significantly lower than in the groups treated only with 80 µg/ml SalB (P<0.05). Fig. 4 , Real-Time PCR demonstrated that following SalB low, medium and high-dose treatments for 48 h, MDR1 expression levels were decreased in a dose-dependent manner. Furthermore, there was a statistical decrease in the MDR1 levels following SalB treatment compared with the untreated negative control group (P<0.01) and no difference compared with the HCT-8/VCR + H 2 O 2 positive control group (P>0.05). Pretreatment with NAC partially reversed the high SalB concentration-induced decrease of MDR1 expression (P<0.01). Figs. 5 and 6 , SalB significantly reduced P-gp protein expression in a dose-dependent manner (P<0.01), however, there was no statistical difference between the high SalB concentration (80 µg/ml) and positive control groups (P>0.05). Following pretreatment with NAC and high SalB for 48 h, P-gp expression levels were significantly increased compared with cells administered with high SalB only (P<0.01). (Figs. 7 and 8 ) demonstrated that following treatment with SalB at 20, 40 and 80 µg/ml, Bcl-2 expression levels in HCT-8/VCR cells were decreased Table IV . IC 50 for chemotherapy drugs used in combination with salvianolic acid B in HCT-8/VCR cells. compared with the negative control group. Additionally, Bax expression levels were increased by SalB compared with the negative control group. No differences in Bcl-2 and Bax expression levels were observed between the positive control and high SalB concentration group. Following pretreatment with NAC and high SalB, the Bcl-2/Bax ratio was significantly increased compared with cells administered with SalB only. Quantification of the Bcl-2/Bax ratios are presented in Fig. 8 .
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Effect of SalB on HCT-8/VCR apoptosis. As demonstrated in
Effect of SalB on MDR1 levels in HCT-8/VCR. As demonstrated in
Effect of SalB on P-gp protein expression in HCT-8/VCR cells. As demonstrated in
Effect of SalB on Bcl-2 and Bax protein expression levels in HCT-8/VCR. Western blot analysis
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Discussion
Primary and secondary MDR in colorectal cancer cells is significantly higher than in other cancers, explaining the low efficacy of chemotherapy for colorectal cancer (13) . Drug efflux mediated by P-gp is the classic mechanism of MDR. It has been demonstrated that P-gp downregulation or efflux inhibition can increase the sensitivity of resistant cells to chemotherapeutic drugs and reverse MDR in colorectal cancer cells (14-18). Drug resistance mediated by anti-apoptosis is also a key MDR mechanism (19) . Apoptosis is also considered the intersection of MDR pathways. ROS are oxygen radicals generated during aerobic metabolism [superoxide (O 2 -) and hydroxyl radicals], with superoxide easily generating free radicals (hydrogen peroxide) (20) . It is known that, compared with sensitive cells, antioxidant levels in resistant cells are higher, and ROS levels are lower (21) (22) (23) (24) (25) . Furthermore, increased ROS Notably, ROS levels in HCT-8/VCR were lower than those in sensitive HCT-8 cells as demonstrated by FCM, indicating that HCT-8/VCR drug resistance may be associated with low ROS levels, which could be increased by SalB. The current study demonstrated that NAC reversed SalB-induced apoptosis, suggesting that SalB reversed MDR in HCT-8/VCR by increasing ROS levels. Subsequently, the expression levels of apoptosis-associated proteins, and drug resistance-associated P-gp, were assessed. It was observed that changes of intracellular ROS levels may secondarily regulate the expression of Bcl-2, Bax and P-gp, affecting apoptosis and drug resistance.
Therefore, we speculated that SalB might reverse multidrug resistance in colorectal cancer HCT-8/VCR cells through two mechanisms related to increased ROS levels in resistant cells: i) Down-regulated P-gp at the gene and protein levels, which results in increased sensitivity of resistant cells to chemotherapy drugs; ii) reduced anti-apoptosis marker (Bcl-2) expression and increased pro-apoptosis (Bax) marker levels decrease mitochondrial transmembrane potential, promote apoptosis of drug resistant cells and reverse multidrug resistance of colorectal cancer HCT-8/VCR cells. More mechanisms of the colorectal cancer multidrug resistance reversed by SalB and reverse resistant effects in body require further investigation.
